I25.732
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code I25.732 refers to a specific condition involving the buildup of fatty deposits, or atherosclerosis, in nonautologous biological coronary artery bypass grafts. This condition is associated with persistent or refractory angina pectoris, which is chest pain that does not respond well to usual treatments. It primarily affects individuals who have undergone coronary artery bypass surgery using biological grafts made from biological tissues, rather than artificial materials. Recognizing and understanding this condition is crucial for managing ongoing heart health concerns.
Causes & Symptoms
Clinical Causes: Progressive build-up of cholesterol and other fatty substances in the grafts over time Degeneration or deterioration of biological graft tissues Presence of other cardiovascular risk factors such as high cholesterol, hypertension, smoking, and diabetes Inflammatory responses within the graft vessels that promote plaque formation Age-related changes leading to vascular wear and tear
Key Symptoms: Persistent chest pain (angina) that does not respond to standard treatments Shortness of breath especially during exertion Fatigue and weakness due to reduced blood flow to the heart Occasional dizziness or lightheadedness Potential signs of heart failure if the condition worsens
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and specialized tests. These may include:
Treatment Protocols: Managing this condition aims to alleviate symptoms, prevent further blockage, and improve quality of life. Treatment options typically include:
Clinical Advice & FAQs
Billing Guidance
Is I25.732 a billable ICD-10 code?
Yes, I25.732 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I25.732?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
